Table 7. Breast cancer summary (N = 2).

Study name (year)	Study type/size	HALP threshold (method)	Outcome(s)	Summary
Importance of HALP Score in Breast Cancer and its Diagnostic Value in Predicting Axillary Lymph Node Status; Duran et al., (2022)	Retrospective N = 307	29.01 (ROC)	Predicting Axillary Lymph Node (ALN) Positivity in Breast Cancer Patients.	Although Low HALP <29.01 predicted increased rate of ALN positivity, HALP Score alone is not advised for ALN positivity.
Correlation of serum NLR, PLR and HALP with efficacy of neoadjuvant chemotherapy and prognosis of triple-negative breast cancer; Lou et al., (2022)	Retrospective N = 92	24.14 (ROC)	NAC efficacy and 3-year OS in triple-negative breast cancer.	Patients with High HALP >24.14 were more likely to have complete response to neoadjuvant chemotherapy and had improved 3-year survival.